Special Edition: Regulatory Focus
Federal court rebuffs FTC effort to apply pharmaceutical standards to dietary supplement substantiation
The decision in the Bayer Corp. contempt case has important implications for the dietary supplement industry, say attorneys Steven Shapiro and Marc Ullman in this guest article: